Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats (Q40183353)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 15, 1978

Language	Label	Description	Also known as
English	Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats	scientific article published on October 15, 1978

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats (English)

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

author name string

B. Rubin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

M. J. Antonaccio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

M. E. Goldberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

D. N. Harris

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

A. G. Itkin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

Z. P. Horovitz

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

R. E. Panasevich

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

R. J. Laffan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A213296

12 January 2023

language of work or name

0 references

publication date

1 October 1978

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

15 October 1978

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=213296

12 January 2023

full work available at URL

https://api.elsevier.com/content/article/PII:0014299978904296?httpAccept=text/xml

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

https://api.elsevier.com/content/article/PII:0014299978904296?httpAccept=text/plain

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

377-388

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Regression of cardiac hypertrophies of various origin

1

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Relation of plasma renin to sodium balance and arterial pressure in experimental renal hypertension

2

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Hypertension of renal origin: evidence for two different mechanisms

4

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Use of angiotensin II antagonists in experimental hypertension

5

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Conversion of angiotensin I to angiotensin II

9

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

A specific orally active inhibitor of angiotensin-converting enzyme in man.

10

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Control of aldosterone secretion in the spontaneously hypertensive rat

11

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Alteration of the Course of Hypertension in the Spontaneously Hypertensive Rat

12

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

The iso-renin angiotensin systems in extrarenal tissue

13

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

14

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Interrelations of renin, angiotensin II, and sodium in hypertension and renal failure

15

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Cardiac hypertrophy in experimental hypertension and its regression following reestablishment of normal blood pressure

16

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Relation of renal arterial pressure to activity of renin-angiotensin system in renal hypertension

19

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Lack of increased renin-angiotensin activity in rats with spontaneous hypertension

20

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Effect of Sodium Restriction on Renal Hypertension and on Renin Activity in the Rat

23

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Synthetic phosphatidylethanolamines as renin inhibitors

24

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

26

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Role of the pressor action of angiotensin II in experimental hypertension.

27

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Hypertension. Definitions, natural histories and consequences

28

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Sodium restriction and reserpine administration in experimental renal hypertension; a correlation of arterial blood pressure responses with the ionic composition of the arterial wall

29

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Sulfonamide compounds with high diuretic activity

30

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

SQ 14,225 (D-3-mercapto-2-methylpropanoyl-l-proline), a novel orally active inhibitor of angiotensin I-converting enzyme

32

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Renin in rats with spontaneous hypertension

33

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Cardiac hypertrophy in spontaneously hypertensive rats

34

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Renin-angiotensin System in the Spontaneously Hypertensive Rat

35

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Central cardiovascular effects of SQ 14,225, an angiotensin-converting enzyme inhibitor in chloralose-anesthetized cats

39

1 reference

10.1016/0014-2999(78)90429-6

https://api.crossref.org/works/10.1016/0014-2999(78)90429-6

12 January 2023

Identifiers

10.1016/0014-2999(78)90429-6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40183353&oldid=1810139230"